TABLE 3.

Knee-extensor maximal isometric and isokinetic torque and 4-m walk and chair-rise time in participants from long-chain n–3 PUFA and placebo groups participating in an 18-wk resistance exercise intervention¹

	Placebo				Long-chain n–3 PUFA
	Men (n = 13)		Women (n = 10)		Men (n = 14)		Women (n = 13)
	Baseline	18 wk	Baseline	18 wk	Baseline	18 wk	Baseline	18 wk
Torque, N·m
Maximal isometric	109.2 ± 33.9	152.5 ± 44.3	76.6 ± 15.3	88.1 ± 17.2	125.1 ± 35.8	164.3 ± 41.4	79.6 ± 10.6	103.5 ± 10.1*
Maximal isokinetic at 30°·s𢄡	131.9 ± 26.2	147.1 ± 38.4	83.5 ± 14.6	88.8 ± 17.3	145.1 ± 36.1	161.0 ± 37.5	92.0 ± 14.5	105.5 ± 8.6
Maximal isokinetic at 90°·s𢄡	84.1 ± 21.4	92.3 ± 22.2	52.6 ± 13.3	55.9 ± 16.5	102.5 ± 29.8	112.8 ± 30.1	56.6 ± 14.8	66.4 ± 14.7
Maximal isokinetic at 240°·s𢄡	45.7 ± 11.4	55.6 ± 14.6	28.2 ± 7.9	33.8 ± 9.4	61.0 ± 15.8	66.4 ± 14.4	34.1 ± 6.9	41.1 ± 7.6
4-m walk time, s	2.22 ± 0.25	1.99 ± 0.28	2.43 ± 0.41	2.25 ± 0.33	2.12 ± 0.27	1.87 ± 0.28	2.36 ± 0.28	2.20 ± 0.37
Chair-rise time, s	7.32 ± 1.10	6.35 ± 1.35	7.83 ± 1.96	6.71 ± 2.11	6.82 ± 1.40	5.80 ± 1.10	8.22 ± 1.51	6.60 ± 1.67

¹All values are means ± SDs, P < 0.05. The data at 18 wk were compared via an ANOVA for group, sex, and sex-by-group interaction effects with baseline values of the outcome measure as a covariate. *Significant interaction effect (group by sex), with the baseline-adjusted 18-wk value greater in the long-chain n–3 PUFA groups than in the placebo groups.